Also, the C1 esterase inhibitor (C1-INH), natural regulator of the complement, kallikrein-kinin, contact and fibrinolytic system, is being investigated for treatment of COVID-19, targeting multiple systems involved in the disease (Adesanya et al., 2021). This evidence concerns the gene SERPING1 and COVID-19.